|Articles|November 9, 2015
Measuring Response to Treatment in Multiple Myeloma
Author(s)C. Ola Landgren
C. Ola Landgren discusses ways to measure response to treatment in multiple myeloma.
Advertisement
C. Ola Landgren, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses ways to measure response to treatment in multiple myeloma. Landgren addressed this topic in a talk last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals in New York City.
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Diagnosed at 25 With Hodgkin's Lymphoma, She Says This Saved Her Life
2
Minimally Invasive Options in Rectal Cancer: TAMIS and Robotic Surgery
3
RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough
4
Why I Don’t Want to Hear “You’ll Beat This” After a Metastatic Breast Cancer Diagnosis
5